Pharvaris (PHVS) had the highest return between December 1, 2022 and December 30, 2022 by a small-cap US stock, returning 425.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Pharvaris (PHVS) | 12/1/2022 - 12/30/2022 | 425.7% |
SS Innovations International Inc Common Stock (SSII) | 12/1/2022 - 12/30/2022 | 304% |
American Coastal Insurance (ACIC) | 12/1/2022 - 12/30/2022 | 229.54% |
Studio City International (MSC) | 12/1/2022 - 12/30/2022 | 140.32% |
Rigel Pharmaceuticals (RIGL) | 12/1/2022 - 12/30/2022 | 119.62% |
Akebia Ther (AKBA) | 12/1/2022 - 12/30/2022 | 113.78% |
Waterdrop Inc ADR (WDH) | 12/1/2022 - 12/30/2022 | 100.6% |
Gaotu Techedu Inc DRC (GOTU) | 12/1/2022 - 12/30/2022 | 83.66% |
iQIYI (IQ) | 12/1/2022 - 12/30/2022 | 82.76% |
Ehang (EH) | 12/1/2022 - 12/30/2022 | 78.01% |
Mama's Creations (MAMA) | 12/1/2022 - 12/30/2022 | 72.6% |
ATRenew Inc DRC (RERE) | 12/1/2022 - 12/30/2022 | 69.01% |
Wave Life Sciences (WVE) | 12/1/2022 - 12/30/2022 | 66.67% |
Oric Pharmaceuticals (ORIC) | 12/1/2022 - 12/30/2022 | 64.07% |
Tuya Inc ADR (TUYA) | 12/1/2022 - 12/30/2022 | 63.24% |
Ardelyx (ARDX) | 12/1/2022 - 12/30/2022 | 62.86% |
Hello (MOMO) | 12/1/2022 - 12/30/2022 | 60.07% |
Amber Road (AMBR) | 12/1/2022 - 12/30/2022 | 59.09% |
89bio (ETNB) | 12/1/2022 - 12/30/2022 | 58.14% |
Celcuity LLC (CELC) | 12/1/2022 - 12/30/2022 | 57.77% |
Altimmune (ALT) | 12/1/2022 - 12/30/2022 | 52.31% |
Astria Therapeutics (ATXS) | 12/1/2022 - 12/30/2022 | 48.31% |
HUYA (HUYA) | 12/1/2022 - 12/30/2022 | 47.39% |
Pulse Biosciences (PLSE) | 12/1/2022 - 12/30/2022 | 44.27% |
ARS Pharmaceuticals (SPRY) | 12/1/2022 - 12/30/2022 | 39.15% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
